Molecule Details
| InChIKey | BQJCRHHNABKAKU-KBQPJGBKSA-N |
|---|---|
| Compound Name | Morphine |
| Canonical SMILES | CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.32 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00295 |
|---|---|
| Drug Name | Morphine |
| CAS Number | 57-27-2 |
| Groups | approved investigational |
| ATC Codes | A07DA52 N02AA51 N02AA01 N02AG01 |
| Description | Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805.[A176035] It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse.[A176050] Morphine is still routinely used today, though there are a number of semi-synthetic opioids of... |
Categories: Alkaloids Analgesics Anesthetics Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Heterocyclic Compounds, Fused-Ring High-risk opioids Hypotensive Agents Narcotics Natural Opium Alkaloids Nervous System Neuraxial Anesthetics Opiate Agonists Opiate Alkaloids Opioid Agonist Opioids P-glycoprotein substrates Peripheral Nervous System Agents Phenanthrenes Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome UGT1A1 Substrates UGT1A3 substrates UGT2B7 substrates
Cross-references: BindingDB: 86258 ChEBI: 17303 CHEMBL70 ChemSpider: 4450907 Drugs Product Database (DPD): 9117 C01516 D08233 PDB: MOI PharmGKB: PA450550 PubChem:5288826 PubChem:46505161 RxCUI: 7052 Therapeutic Targets Database: DAP000071 Wikipedia: Morphine ZINC: ZINC000003812983
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P35372 | OPRM1 | Homo sapiens | Human | PF00001 | 8.4 | Ki | ChEMBL;BindingDB |
| P41145 | OPRK1 | Homo sapiens | Human | PF00001 | 7.2 | Ki | ChEMBL;BindingDB |
| P08913 | ADRA2A | Homo sapiens | Human | PF00001 | 6.8 | Ki | ChEMBL |
| P41143 | OPRD1 | Homo sapiens | Human | PF00001 | 6.8 | Ki | ChEMBL;BindingDB |
DrugBank Target Actions (14)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P02768 | ALB | Albumin | binder | carriers |
| P06133 | P06133 | UDP-glucuronosyltransferase 2B4 | substrate | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P10632 | CYP2C8 | Cytochrome P450 2C8 | substrate | enzymes |
| P16662 | UGT2B7 | UDP-glucuronosyltransferase 2B7 | substrate | enzymes |
| P22309 | UGT1A1 | UDP-glucuronosyltransferase 1A1 | substrate | enzymes |
| P35503 | P35503 | UDP-glucuronosyltransferase 1A3 | substrate | enzymes |
| P54855 | P54855 | UDP-glucuronosyltransferase 2B15 | substrate | enzymes |
| Q9HAW9 | Q9HAW9 | UDP-glucuronosyltransferase 1A8 | substrate | enzymes |
| Q9Y6Y9 | LY96 | Lymphocyte antigen 96 | activator | targets |
| P35372 | OPRM1 | Mu-type opioid receptor | agonist | targets |
| P41143 | OPRD1 | Delta-type opioid receptor | agonist | targets |
| P41145 | OPRK1 | Kappa-type opioid receptor | agonist | targets |
| P08183 | ABCB1 | ATP-dependent translocase ABCB1 | substrate | transporters |